Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by HippygirL74on Feb 21, 2015 1:37am
278 Views
Post# 23450661

One more week before...

One more week before...before the early tax loss sellers come back circa March 2nd or 3rd. NRI has $58.3 MM and 10,774,757 shares. That's $5.41 cash per share. It's just a matter of time before the sp gets back to cash. Double bonus, tax loss selling and buy back after 30 days. Then the silent analyst after getting their fill of shares will announce that NRI is a Speculative Buy with a nice cash cushion and huge potential. Let's say that the sp gets to $6.41 (just as an example of any number), then they will say that the sp is cheap because you get the cash and the rest of the company's assets for $1.00 per share. Then comes the WF10 news as the potential new drug gets back on track. It happens all over again. And ROW P2? Another catalyst. imo, it is time to load up while we are still under cash levels. Maybe sell some on the way up to get your cost base to zero and ride the rest out. I am still adding shares. It's like a gift to me. So obvious. I'm buying before the pros start promoting it again. Good night everyone.
Bullboard Posts